As of 03 Nov 2026 06:02 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2021/036 (21 Jul 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear dropsaffected product · inferred from phrasing | Out of stock, as stated | April 2022precision: a month · window end 30 Apr 2022, derived from “April 2022” | notice of 21 Jul 2021 |
| Alternative topical combination steroid and antibacterial preparations for the earclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 21 Jul 2021 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Locorten Vioform
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 21 Jul 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 21 Jul 2021 | Medicine Supply Notification: Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution - Updated | Supply notification | Tier 2 | MSN/2021/036 |
Also recorded under
Bracketed names seen in this medicine's notice titles: flumetasone. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2021)22 Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops · issued 03 Aug 2021 · valid until April 2022, as stated · matched by name PDF ↗